| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.12e-09 | 46 | 154 | 8 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 COL6A6 PAPLN VWA1 COL1A2 | 2.40e-07 | 188 | 154 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | molecular adaptor activity | SHANK1 ARID3A MAPT INSM1 CALCOCO1 BCORL1 DVL2 OBSL1 PEX6 BCL11A ECPAS WNK1 LPIN3 DLGAP3 KMT2D FIZ1 ZAR1 STRN4 ELK1 AJUBA MBD2 KDM1A TNS3 PCNT COL1A2 | 4.12e-05 | 1356 | 154 | 25 | GO:0060090 |
| GeneOntologyMolecularFunction | enzyme regulator activity | COL4A3 COL7A1 CLSTN3 FN1 PLEKHG4 PAPLN ARHGEF17 WNK1 DENND2B ITIH5 TAOK2 PPP1R26 WDR91 ARHGAP22 TBC1D10B DENND4B RIN2 KNDC1 BSN DMWD AJUBA RGL2 TNS3 PINK1 MTSS2 | 8.47e-05 | 1418 | 154 | 25 | GO:0030234 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 9.40e-05 | 12 | 154 | 3 | GO:0048407 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | CIART PTF1A ASCL5 INSM1 CALCOCO1 ARX ZBTB22 GLIS3 NKX3-2 LHX3 BCL11A ZBTB7B ZNF446 BSX LHX1 WIZ EGR2 EGR4 BHLHA15 ZNF335 ELK1 KDM1A | 3.05e-04 | 1271 | 154 | 22 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | CIART PTF1A ASCL5 INSM1 CALCOCO1 ARX ZBTB22 GLIS3 NKX3-2 LHX3 BCL11A HMX2 ZBTB7B ZNF446 BSX LHX1 WIZ EGR2 EGR4 BHLHA15 BARHL1 ZNF335 ELK1 KDM1A | 3.37e-04 | 1459 | 154 | 24 | GO:0000977 |
| GeneOntologyMolecularFunction | inositol-1,4,5-trisphosphate 3-kinase activity | 3.51e-04 | 4 | 154 | 2 | GO:0008440 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | PTF1A ASCL5 ARX GLIS3 LHX3 ZBTB7B BSX KMT2D EGR2 EGR4 BHLHA15 BARHL1 ELK1 | 4.11e-04 | 560 | 154 | 13 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | PTF1A ASCL5 ARX GLIS3 LHX3 ZBTB7B BSX KMT2D EGR2 EGR4 BHLHA15 BARHL1 ELK1 | 4.54e-04 | 566 | 154 | 13 | GO:0001216 |
| GeneOntologyMolecularFunction | inositol tetrakisphosphate kinase activity | 5.82e-04 | 5 | 154 | 2 | GO:0051765 | |
| GeneOntologyMolecularFunction | inositol trisphosphate kinase activity | 5.82e-04 | 5 | 154 | 2 | GO:0051766 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | CIART PTF1A ASCL5 INSM1 CALCOCO1 ARX ZBTB22 GLIS3 NKX3-2 LHX3 BCL11A ZBTB7B ZNF446 BSX WIZ EGR2 EGR4 BHLHA15 ZNF335 ELK1 KDM1A | 5.87e-04 | 1244 | 154 | 21 | GO:0000978 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SHANK1 ARID3A MAPT CALCOCO1 BCORL1 DVL2 OBSL1 PEX6 BCL11A WNK1 LPIN3 KMT2D FIZ1 ZAR1 STRN4 ELK1 AJUBA KDM1A TNS3 COL1A2 | 6.15e-04 | 1160 | 154 | 20 | GO:0030674 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | PTF1A ASCL5 INSM1 ARX ZBTB22 GLIS3 NKX3-2 LHX3 BCL11A HMX2 ZBTB7B ZNF446 BSX LHX1 KMT2D WIZ EGR2 EGR4 DBX1 BHLHA15 BARHL1 ELK1 | 1.24e-03 | 1412 | 154 | 22 | GO:0000981 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | PLEKHG4 ARHGEF17 DENND2B ARHGAP22 TBC1D10B DENND4B RIN2 KNDC1 RGL2 TNS3 MTSS2 | 1.96e-03 | 507 | 154 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | PLEKHG4 ARHGEF17 DENND2B ARHGAP22 TBC1D10B DENND4B RIN2 KNDC1 RGL2 TNS3 MTSS2 | 1.96e-03 | 507 | 154 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.14e-03 | 231 | 154 | 7 | GO:0005085 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SHANK1 CLSTN3 FN1 PLEKHG4 MAPT ARX DVL2 OBSL1 SLITRK3 LHX3 BCL11A PAK6 TAOK2 LHX1 IGFALS PTPRM EGR2 ZNF335 KNDC1 KDM1A | 2.84e-06 | 802 | 156 | 20 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SHANK1 CLSTN3 FN1 PLEKHG4 MAPT ARX DVL2 OBSL1 SLITRK3 LHX3 BCL11A PAK6 TAOK2 LHX1 IGFALS PTPRM EGR2 ZNF335 KNDC1 KDM1A | 3.89e-06 | 819 | 156 | 20 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SHANK1 CLSTN3 FN1 PLEKHG4 MAPT ARX DVL2 OBSL1 SLITRK3 LHX3 BCL11A PAK6 TAOK2 LHX1 IGFALS PTPRM EGR2 ZNF335 KNDC1 KDM1A | 4.42e-06 | 826 | 156 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron projection development | SHANK1 CDK16 CLSTN3 FN1 PLEKHG4 KIF26A MAPT PAK4 ARX DVL2 OBSL1 SLITRK3 LHX3 BCL11A PAK6 GPRIN1 TAOK2 LHX1 IGFALS PTPRM EGR2 BHLHA15 ZNF335 KNDC1 KDM1A | 1.23e-05 | 1285 | 156 | 25 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | SHANK1 CDK16 CLSTN3 FN1 PLEKHG4 KIF26A MAPT INSM1 PAK4 ARX DVL2 OBSL1 SLITRK3 LHX3 BCL11A PAK6 GPRIN1 WNK1 TAOK2 LHX1 IGFALS PTPRM EGR2 BHLHA15 ZNF335 KNDC1 KDM1A | 1.36e-05 | 1463 | 156 | 27 | GO:0048666 |
| GeneOntologyCellularComponent | basement membrane | COL2A1 COL4A1 COL4A3 COL7A1 COL17A1 FN1 PAPLN VWA1 FREM2 RELL2 | 2.87e-08 | 122 | 157 | 10 | GO:0005604 |
| GeneOntologyCellularComponent | collagen trimer | 3.27e-07 | 88 | 157 | 8 | GO:0005581 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 4.14e-07 | 21 | 157 | 5 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 COL6A6 PAPLN VWA1 ITIH5 FREM2 RELL2 FGFBP3 COL1A2 | 1.15e-05 | 530 | 157 | 15 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 COL6A6 PAPLN VWA1 ITIH5 FREM2 IGFALS RELL2 FGFBP3 COL1A2 | 3.61e-05 | 656 | 157 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 COL6A6 PAPLN VWA1 ITIH5 FREM2 IGFALS RELL2 FGFBP3 COL1A2 | 3.74e-05 | 658 | 157 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | chromatin | PTF1A BICRA ASCL5 CALCOCO1 ARX ZBTB22 NKX3-2 OIP5 LHX3 BCL11A HMX2 ZNF446 BSX LHX1 SF3B1 EGR2 EGR4 DBX1 BHLHA15 BARHL1 FIZ1 ELK1 MBD2 KDM1A PINK1 | 1.11e-04 | 1480 | 157 | 25 | GO:0000785 |
| GeneOntologyCellularComponent | collagen type IV trimer | 8.24e-04 | 6 | 157 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 9.35e-04 | 332 | 157 | 9 | GO:0005788 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.52e-03 | 8 | 157 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.52e-03 | 8 | 157 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.52e-03 | 8 | 157 | 2 | GO:0098645 | |
| Domain | Collagen | 5.26e-07 | 85 | 155 | 8 | IPR008160 | |
| Domain | Collagen | 5.26e-07 | 85 | 155 | 8 | PF01391 | |
| Domain | Homeobox_CS | 1.65e-04 | 186 | 155 | 8 | IPR017970 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 BCAR1 ADGRA2 COL1A2 | 1.49e-10 | 74 | 104 | 10 | M160 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 5.22e-10 | 41 | 104 | 8 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 9.50e-10 | 44 | 104 | 8 | M27812 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.42e-08 | 61 | 104 | 8 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.10e-08 | 64 | 104 | 8 | M26953 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.04e-08 | 67 | 104 | 8 | M26999 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 4.10e-08 | 46 | 104 | 7 | M198 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.33e-08 | 76 | 104 | 8 | MM14867 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.33e-08 | 76 | 104 | 8 | MM14573 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.01e-07 | 85 | 104 | 8 | M16441 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.05e-07 | 61 | 104 | 7 | M27103 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.14e-07 | 90 | 104 | 8 | M631 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 COL6A6 COL1A2 | 8.97e-07 | 140 | 104 | 9 | M587 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.70e-06 | 50 | 104 | 6 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.42e-06 | 53 | 104 | 6 | MM14566 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.41e-06 | 32 | 104 | 5 | MM14924 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 3.58e-06 | 15 | 104 | 4 | M27161 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 8.85e-06 | 66 | 104 | 6 | M18 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.24e-05 | 20 | 104 | 4 | MM15061 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.61e-05 | 199 | 104 | 9 | M7253 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.01e-05 | 76 | 104 | 6 | M27219 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.09e-05 | 114 | 104 | 7 | MM14571 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.13e-05 | 57 | 104 | 5 | MM14713 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.61e-05 | 30 | 104 | 4 | MM15517 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.66e-05 | 58 | 104 | 5 | M2049 | |
| Pathway | WP_FOCAL_ADHESION | 7.18e-05 | 187 | 104 | 8 | MM15913 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.24e-05 | 59 | 104 | 5 | M27218 | |
| Pathway | WP_FOCAL_ADHESION | 1.11e-04 | 199 | 104 | 8 | M39402 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 COL6A6 COL1A2 | 1.21e-04 | 258 | 104 | 9 | MM14572 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.70e-04 | 38 | 104 | 4 | MM14969 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.29e-04 | 41 | 104 | 4 | M27778 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.52e-04 | 42 | 104 | 4 | M7169 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.77e-04 | 43 | 104 | 4 | M53 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.94e-04 | 18 | 104 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.94e-04 | 18 | 104 | 3 | MM14882 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.47e-04 | 19 | 104 | 3 | MM15512 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 COL6A6 COL1A2 | 3.72e-04 | 300 | 104 | 9 | M610 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.86e-04 | 84 | 104 | 5 | M7098 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.91e-04 | 47 | 104 | 4 | MM14925 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A1 COL4A3 FN1 COL6A6 BCAR1 EGR2 EGR4 FGFBP3 ELK1 TNS3 COL1A2 | 5.41e-04 | 532 | 104 | 12 | M27870 |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | COL4A1 COL7A1 GJD2 REPS1 KIF26A DVL2 DENND2B TBC1D10B SYNJ1 DENND4B RIN2 REPS2 VPS37D COL1A2 | 8.63e-04 | 725 | 104 | 14 | M27507 |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 8.96e-04 | 26 | 104 | 3 | M27053 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A1 COL4A3 FN1 COL6A6 BCAR1 EGR2 FGFBP3 TNS3 COL1A2 | 1.03e-03 | 418 | 104 | 10 | MM15587 |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.12e-03 | 28 | 104 | 3 | MM14711 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.19e-03 | 63 | 104 | 4 | M11187 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.37e-03 | 30 | 104 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.37e-03 | 30 | 104 | 3 | M27216 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.50e-03 | 67 | 104 | 4 | MM15327 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.50e-03 | 67 | 104 | 4 | MM15345 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 1.88e-03 | 9 | 104 | 2 | MM14966 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | COL7A1 GJD2 REPS1 KIF26A DVL2 DENND2B TBC1D10B SYNJ1 DENND4B RIN2 REPS2 VPS37D | 2.30e-03 | 630 | 104 | 12 | M11480 |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.33e-03 | 10 | 104 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.33e-03 | 10 | 104 | 2 | MM1560 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 2.73e-03 | 38 | 104 | 3 | MM15456 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.75e-03 | 79 | 104 | 4 | M27643 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | COL7A1 GJD2 REPS1 KIF26A DVL2 DENND2B TBC1D10B SYNJ1 DENND4B RIN2 REPS2 VPS37D | 2.80e-03 | 645 | 104 | 12 | MM15232 |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 2.84e-03 | 11 | 104 | 2 | M48099 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.84e-03 | 11 | 104 | 2 | M15422 | |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 2.94e-03 | 39 | 104 | 3 | M29793 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 2.94e-03 | 39 | 104 | 3 | M10735 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | REPS1 ARID3A KIF26A BICRA PEX6 PAPLN WNK1 ADGRA2 BAHD1 PLEKHH3 C2CD2L TAOK2 PPP1R26 LPIN3 PRR12 NHSL1 KMT2D AATK WIZ SYNJ1 ZNF335 OSBPL5 STRN4 NAV1 DISP2 ZC3H7B DMWD RGL2 PCNT | 2.12e-14 | 1105 | 158 | 29 | 35748872 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK16 MAPT PAK4 GIGYF1 BCAR1 PAK6 ARHGEF17 WNK1 DENND2B ENKD1 ITPKB LPIN3 NHSL1 TBC1D10B SLC12A2 SYNJ1 CASKIN2 NAV1 MTCL1 RGL2 TNS3 MTSS2 | 6.65e-11 | 861 | 158 | 22 | 36931259 |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 4.17e-10 | 62 | 158 | 8 | 28344315 | |
| Pubmed | COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 COL6A6 VWA1 ITIH5 COL1A2 | 2.31e-09 | 153 | 158 | 10 | 25037231 | |
| Pubmed | SHANK1 APC2 CALCOCO1 ZBTB22 DVL2 BCL11A PPFIA3 TAOK2 WDR91 DLGAP3 SF3B1 WIZ SYNJ1 STRN4 FBXO41 NAV1 MTCL1 BSN KDM1A MTSS2 PCNT | 3.16e-09 | 963 | 158 | 21 | 28671696 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.26e-08 | 135 | 158 | 9 | 28675934 | |
| Pubmed | 2.83e-08 | 8 | 158 | 4 | 3997552 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 2.83e-08 | 8 | 158 | 4 | 11867580 | |
| Pubmed | 7.95e-08 | 167 | 158 | 9 | 22159717 | ||
| Pubmed | 8.43e-08 | 10 | 158 | 4 | 9415455 | ||
| Pubmed | 1.19e-07 | 175 | 158 | 9 | 28071719 | ||
| Pubmed | ZNF703 PAK4 BCAR1 PPFIA3 GPRIN1 TERF2 NHSL1 TBC1D10B KMT2D WIZ SLC12A2 PTPRM CASKIN2 PHLPP1 DMWD AJUBA TNS3 PCNT COL1A2 | 3.34e-07 | 1049 | 158 | 19 | 27880917 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF703 ARID3A BICRA BCORL1 BCL11A PRR12 PCGF6 KMT2D WIZ EGR2 KDM1A | 6.79e-07 | 351 | 158 | 11 | 38297188 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | BICRA APC2 GLIS3 BCAR1 WNK1 LARP4B AATK SLC12A2 EGR2 BSN AJUBA PCNT | 7.11e-07 | 430 | 158 | 12 | 35044719 |
| Pubmed | MAPT BICRA DVL2 OBSL1 PEX6 BCL11A GIGYF1 PPFIA3 ENKD1 FBXL6 C2CD2L TBC1D10B LARP4B SOWAHA WIZ FIZ1 MBD2 KDM1A SPATC1L | 8.43e-07 | 1116 | 158 | 19 | 31753913 | |
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 9409248 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 9169408 | ||
| Pubmed | 9.85e-07 | 225 | 158 | 9 | 12168954 | ||
| Pubmed | KIF26A PAK4 ECPAS ADGRA2 BAHD1 TAOK2 ZFYVE28 CASKIN2 OSBPL5 FBXO41 BSN ZC3H7B KDM1A | 1.00e-06 | 529 | 158 | 13 | 14621295 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | PTF1A ARX ZBTB22 NKX3-2 HMX2 ZBTB7B BSX LHX1 EGR2 EGR4 BHLHA15 BARHL1 ELK1 | 1.37e-06 | 544 | 158 | 13 | 28473536 |
| Pubmed | Non-cell autonomous control of precerebellar neuron migration by Slit and Robo proteins. | 1.51e-06 | 19 | 158 | 4 | 29343636 | |
| Pubmed | 1.51e-06 | 19 | 158 | 4 | 15689378 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.69e-06 | 79 | 158 | 6 | 18757743 | |
| Pubmed | Genetic dissection of the function of hindbrain axonal commissures. | 1.88e-06 | 20 | 158 | 4 | 20231872 | |
| Pubmed | 2.31e-06 | 21 | 158 | 4 | 27856617 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.78e-06 | 86 | 158 | 6 | 28327460 | |
| Pubmed | CLSTN3 OBSL1 BCL11A ARHGEF17 C2CD2L DENND4B NAV1 DISP2 MTCL1 PCNT PDZD2 | 2.85e-06 | 407 | 158 | 11 | 12693553 | |
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 3.18e-06 | 7 | 158 | 3 | 10716744 | |
| Pubmed | Cell surface tumor endothelial markers are conserved in mice and humans. | 3.18e-06 | 7 | 158 | 3 | 11559528 | |
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 23273220 | ||
| Pubmed | Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. | 3.18e-06 | 7 | 158 | 3 | 9334230 | |
| Pubmed | 3.26e-06 | 50 | 158 | 5 | 23658023 | ||
| Pubmed | COL16A1 BCORL1 GIGYF1 TERF2 PLEKHH3 PPP1R26 NHSL1 SYNJ1 CASKIN2 DENND4B ZNF335 STRN4 MTCL1 COL1A2 | 3.51e-06 | 689 | 158 | 14 | 36543142 | |
| Pubmed | BCORL1 DVL2 ECPAS PRR12 KMT2D WIZ SYNJ1 FIZ1 NAV1 KDM1A PCNT | 3.67e-06 | 418 | 158 | 11 | 34709266 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | PTF1A INSM1 ARX NKX3-2 LHX3 HMX2 ZBTB7B TERF2 BSX KMT2D EGR2 DBX1 BHLHA15 BARHL1 ZNF335 ELK1 | 4.25e-06 | 908 | 158 | 16 | 19274049 |
| Pubmed | SHANK1 MAPT OGFR DVL2 PPFIA3 GPRIN1 C2CD2L TAOK2 NHSL1 DLGAP3 LARP4B SF3B1 SYNJ1 STRN4 KNDC1 FBXO41 NAV1 BSN | 4.71e-06 | 1139 | 158 | 18 | 36417873 | |
| Pubmed | Extracellular-matrix gene expression during mouse submandibular gland development. | 5.07e-06 | 8 | 158 | 3 | 9382709 | |
| Pubmed | 5.07e-06 | 8 | 158 | 3 | 1377218 | ||
| Pubmed | The LIM protein Ajuba influences p130Cas localization and Rac1 activity during cell migration. | 5.07e-06 | 8 | 158 | 3 | 15728191 | |
| Pubmed | 5.07e-06 | 8 | 158 | 3 | 1383086 | ||
| Pubmed | 5.07e-06 | 8 | 158 | 3 | 10382266 | ||
| Pubmed | 5.73e-06 | 210 | 158 | 8 | 16537572 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ZNF703 FN1 BCORL1 OIP5 PPFIA3 ECPAS GPRIN1 ARHGEF17 ZFYVE28 FREM2 WIZ DENND4B MTCL1 COL1A2 | 7.42e-06 | 736 | 158 | 14 | 29676528 |
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 20004188 | ||
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 9878537 | ||
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 8900172 | ||
| Pubmed | 8.91e-06 | 29 | 158 | 4 | 22613833 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.48e-05 | 11 | 158 | 3 | 7500359 | |
| Pubmed | 1.96e-05 | 12 | 158 | 3 | 26937009 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.96e-05 | 12 | 158 | 3 | 12180907 | |
| Pubmed | Requirement of LIM domains for LIM1 function in mouse head development. | 2.05e-05 | 2 | 158 | 2 | 10862151 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 7963647 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 29404406 | ||
| Pubmed | Genetic and functional analyses of early growth response (EGR) family genes in schizophrenia. | 2.05e-05 | 2 | 158 | 2 | 22691714 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 33305316 | ||
| Pubmed | Characterization of the aberrant splicing of DVL2 induced by cancer-associated SF3B1 mutation. | 2.05e-05 | 2 | 158 | 2 | 33561744 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 8020944 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 9535558 | ||
| Pubmed | The role of Bapx1 (Nkx3.2) in the development and evolution of the axial skeleton. | 2.05e-05 | 2 | 158 | 2 | 11523821 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 34424299 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 30204936 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26711547 | ||
| Pubmed | A second fibronectin-binding region is present in collagen alpha chains. | 2.05e-05 | 2 | 158 | 2 | 2229073 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 34225581 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 32200603 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 23580654 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 24375478 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 16740130 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26654447 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 38824479 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17169544 | ||
| Pubmed | The direct binding of collagen XVII and collagen IV is disrupted by pemphigoid autoantibodies. | 2.05e-05 | 2 | 158 | 2 | 30089857 | |
| Pubmed | Parkinson's disease-associated PINK1 G309D mutation increases abnormal phosphorylation of Tau. | 2.05e-05 | 2 | 158 | 2 | 25899925 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 10469600 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 17459242 | ||
| Pubmed | With no lysine L-WNK1 isoforms are negative regulators of the K+-Cl- cotransporters. | 2.05e-05 | 2 | 158 | 2 | 27170636 | |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 28612031 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 35187752 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 26138234 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 10660600 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.25e-05 | 184 | 158 | 7 | 32908313 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 2.54e-05 | 13 | 158 | 3 | 9833687 | |
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 2.54e-05 | 13 | 158 | 3 | 21173153 | |
| Pubmed | 2.76e-05 | 77 | 158 | 5 | 19505873 | ||
| Pubmed | SHANK1 FN1 MAPT CALCOCO1 BCL11A BCAS1 PPFIA3 ARHGEF17 ITPKB NHSL1 DLGAP3 SF3B1 SYNJ1 STRN4 KNDC1 FBXO41 NAV1 SAMM50 BSN | 2.90e-05 | 1431 | 158 | 19 | 37142655 | |
| Pubmed | REPS1 FN1 APC2 CALCOCO1 PPFIA3 DLGAP3 TBC1D10B FBXO41 REPS2 MTSS2 | 2.96e-05 | 430 | 158 | 10 | 32581705 | |
| Pubmed | 2.98e-05 | 39 | 158 | 4 | 33580754 | ||
| Pubmed | Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. | 2.98e-05 | 39 | 158 | 4 | 21606205 | |
| Pubmed | 3.00e-05 | 130 | 158 | 6 | 12421765 | ||
| Pubmed | 3.23e-05 | 14 | 158 | 3 | 32541010 | ||
| Pubmed | 3.96e-05 | 83 | 158 | 5 | 28794006 | ||
| Pubmed | 4.01e-05 | 42 | 158 | 4 | 26166575 | ||
| Pubmed | Sprouty1 haploinsufficiency prevents renal agenesis in a model of Fraser syndrome. | 4.02e-05 | 15 | 158 | 3 | 23064016 | |
| Pubmed | Head bobber: an insertional mutation causes inner ear defects, hyperactive circling, and deafness. | 4.02e-05 | 15 | 158 | 3 | 22383091 | |
| Pubmed | Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. | 4.02e-05 | 15 | 158 | 3 | 9804427 | |
| Pubmed | 4.02e-05 | 15 | 158 | 3 | 38018454 | ||
| Pubmed | 4.93e-05 | 16 | 158 | 3 | 15878328 | ||
| Pubmed | 4.93e-05 | 16 | 158 | 3 | 17881772 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | SHANK1 FN1 OBSL1 WNK1 PLEKHH3 LARP4B OSBPL5 FBXO41 NAV1 KDM1A | 5.40e-05 | 462 | 158 | 10 | 31138677 |
| Pubmed | 5.74e-05 | 146 | 158 | 6 | 27068509 | ||
| Interaction | TOP3B interactions | REPS1 ARID3A KIF26A BICRA DVL2 PEX6 PAPLN WNK1 ADGRA2 BAHD1 PLEKHH3 FBXL6 C2CD2L TAOK2 PPP1R26 LPIN3 PRR12 NHSL1 LARP4B KMT2D AATK WIZ SYNJ1 ZNF335 OSBPL5 STRN4 NAV1 DISP2 ZC3H7B DMWD RGL2 PCNT | 5.71e-08 | 1470 | 154 | 32 | int:TOP3B |
| Interaction | YWHAG interactions | CDK16 FN1 MAPT PAK4 DVL2 GIGYF1 BCAR1 PAK6 ARHGEF17 WNK1 DENND2B ENKD1 ITPKB C2CD2L TAOK2 LPIN3 NHSL1 TBC1D10B SYNJ1 CASKIN2 NAV1 MTCL1 DMWD RGL2 TNS3 PINK1 MTSS2 | 8.41e-07 | 1248 | 154 | 27 | int:YWHAG |
| Interaction | YWHAH interactions | CDK16 FN1 MAPT PAK4 GIGYF1 BCAR1 PAK6 ARHGEF17 WNK1 DENND2B ENKD1 LPIN3 NHSL1 TBC1D10B SLC12A2 SYNJ1 CASKIN2 OSBPL5 NAV1 MTCL1 DMWD RGL2 TNS3 MTSS2 PCNT | 9.69e-07 | 1102 | 154 | 25 | int:YWHAH |
| Interaction | TGFBI interactions | 1.15e-06 | 25 | 154 | 5 | int:TGFBI | |
| Interaction | EGR2 interactions | 6.82e-06 | 171 | 154 | 9 | int:EGR2 | |
| Interaction | AP2A1 interactions | 1.96e-05 | 299 | 154 | 11 | int:AP2A1 | |
| Interaction | YWHAB interactions | CDK16 FN1 MAPT PAK4 DVL2 GIGYF1 BCAR1 PAK6 ARHGEF17 WNK1 DENND2B ITPKB LPIN3 NHSL1 TBC1D10B NAV1 MTCL1 DMWD RGL2 TNS3 MTSS2 | 3.07e-05 | 1014 | 154 | 21 | int:YWHAB |
| Interaction | LAIR2 interactions | 3.55e-05 | 49 | 154 | 5 | int:LAIR2 | |
| Interaction | KCTD3 interactions | 3.87e-05 | 164 | 154 | 8 | int:KCTD3 | |
| Interaction | MMP2 interactions | 5.48e-05 | 87 | 154 | 6 | int:MMP2 | |
| Interaction | MAG interactions | 6.71e-05 | 29 | 154 | 4 | int:MAG | |
| Interaction | BGN interactions | 7.70e-05 | 30 | 154 | 4 | int:BGN | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | SHANK1 BICRA PAK4 FAM83E PPFIA3 KIRREL2 ZNF446 PRR12 GIPR ITPKC LIPE FIZ1 STRN4 DACT3 DMWD SERTAD1 | 4.76e-06 | 1192 | 160 | 16 | chr19q13 |
| Cytoband | 19q13.3 | 2.01e-04 | 82 | 160 | 4 | 19q13.3 | |
| Cytoband | 15q15.1 | 6.02e-04 | 47 | 160 | 3 | 15q15.1 | |
| Cytoband | 16q22.1 | 6.16e-04 | 110 | 160 | 4 | 16q22.1 | |
| Cytoband | 8p11.23 | 7.79e-04 | 12 | 160 | 2 | 8p11.23 | |
| GeneFamily | Collagens | 2.69e-10 | 46 | 108 | 8 | 490 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 4.98e-05 | 67 | 108 | 5 | 519 | |
| GeneFamily | LIM class homeoboxes | 2.24e-03 | 12 | 108 | 2 | 522 | |
| GeneFamily | Fibronectin type III domain containing | 2.73e-03 | 160 | 108 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.81e-03 | 161 | 108 | 5 | 593 | |
| GeneFamily | Ankyrin repeat domain containing | 3.32e-03 | 242 | 108 | 6 | 403 | |
| Coexpression | NABA_COLLAGENS | 1.86e-10 | 43 | 159 | 8 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 2.26e-10 | 44 | 159 | 8 | M3005 | |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 COL6A6 PAPLN VWA1 IGFALS COL1A2 | 1.04e-07 | 270 | 159 | 12 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 COL6A6 PAPLN VWA1 IGFALS COL1A2 | 1.27e-07 | 275 | 159 | 12 | M5884 |
| Coexpression | BENPORATH_SUZ12_TARGETS | COL2A1 CDK16 ZNF703 GJD2 CRLF1 MAPT PTF1A INSM1 NKX3-2 SLITRK3 HMX2 ADGRA2 ITPKB ZFYVE28 NPHS2 EGR2 EGR4 BARHL1 ZAR1 REPS2 AJUBA PDZD2 | 3.24e-07 | 1035 | 159 | 22 | M9898 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | COL4A1 FN1 NKX3-2 ARHGEF17 ADGRA2 DENND2B ITIH5 ITPKB SMTN C2CD2L SLC12A2 PTPRM EGR2 DACT3 TNS3 PDZD2 SERTAD1 COL1A2 | 1.73e-06 | 795 | 159 | 18 | M39050 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | COL4A1 COL16A1 FN1 VWA1 KIRREL2 ITIH5 SMTN AATK CASKIN2 TNS3 | 5.92e-06 | 268 | 159 | 10 | M45796 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | COL2A1 CCDC184 COL16A1 CRLF1 INSM1 BCORL1 DUSP15 BCL11A VWA1 GPRIN1 KCNH4 AATK BSN | 1.05e-05 | 493 | 159 | 13 | M1951 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | COL2A1 CCDC184 COL16A1 CRLF1 INSM1 BCORL1 DUSP15 BCL11A VWA1 GPRIN1 KCNH4 AATK BSN | 1.32e-05 | 504 | 159 | 13 | MM830 |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | COL2A1 GJD2 CRLF1 CIART MAPT PTF1A NKX3-2 SLITRK3 DUSP15 LHX3 HMX2 ADGRA2 ITIH5 ZFYVE28 SOWAHA EGR2 EGR4 BARHL1 REPS2 PDZD2 | 1.46e-05 | 1115 | 159 | 20 | M10371 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | GJD2 PTF1A INSM1 SLITRK3 LHX3 HMX2 GPRIN1 NPHS2 SOWAHA AATK DBX1 BARHL1 KNDC1 BSN | 1.58e-05 | 591 | 159 | 14 | M2019 |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL4A1 COL7A1 COL16A1 FN1 VWA1 BCAR1 ARHGEF17 DENND2B ITIH5 LPIN3 PTPRM C7 TNS3 MTSS2 SERTAD1 COL1A2 | 1.85e-05 | 767 | 159 | 16 | M39209 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | GJD2 PTF1A INSM1 SLITRK3 LHX3 HMX2 GPRIN1 NPHS2 SOWAHA AATK DBX1 BARHL1 KNDC1 BSN | 1.91e-05 | 601 | 159 | 14 | MM866 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS | COL2A1 KIF26A INSM1 GLIS3 GPRIN1 ENKD1 FGFBP3 ALPK3 MTCL1 C7 | 2.21e-05 | 312 | 159 | 10 | M39161 |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_31_PRECICTIVE_ICB_RESISTANCE | 3.28e-05 | 201 | 159 | 8 | MM17086 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 4.48e-05 | 272 | 159 | 9 | M1938 | |
| Coexpression | CUI_TCF21_TARGETS_DN | 4.65e-05 | 33 | 159 | 4 | MM664 | |
| Coexpression | CUI_TCF21_TARGETS_DN | 5.25e-05 | 34 | 159 | 4 | M6937 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 5.90e-05 | 35 | 159 | 4 | MM17054 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 5.92e-05 | 282 | 159 | 9 | MM822 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | COL4A1 FN1 VWA1 ITIH5 SMTN SLC12A2 SAMM50 PDZD2 SERTAD1 COL1A2 | 8.25e-05 | 365 | 159 | 10 | M39018 |
| Coexpression | BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN | 8.53e-05 | 118 | 159 | 6 | M34005 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.01e-04 | 40 | 159 | 4 | M5887 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 1.02e-04 | 303 | 159 | 9 | M39040 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ZNF703 COL16A1 MAPT CALCOCO1 GLIS3 DUSP15 BCAS1 BCAR1 HMX2 ECPAS NHSL1 AATK PTPRM NAV1 REPS2 MBD2 PINK1 INVS | 1.32e-04 | 1102 | 159 | 18 | M2369 |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 1.40e-04 | 17 | 159 | 3 | M47995 | |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 CRLF1 COL17A1 FN1 COL6A6 INHA PAPLN VWA1 ITIH5 FREM2 IGFALS FGFBP3 COL1A2 | 1.41e-04 | 1008 | 159 | 17 | MM17056 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B | BORCS6 COL4A1 COL7A1 CRLF1 COL17A1 ARX OIP5 ITPKC FGFBP3 OSBPL5 ALPK3 AJUBA | 1.51e-04 | 554 | 159 | 12 | M2244 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ZNF703 COL16A1 MAPT CALCOCO1 GLIS3 DUSP15 BCAS1 BCAR1 HMX2 ECPAS NHSL1 AATK PTPRM NAV1 REPS2 MBD2 PINK1 INVS | 1.69e-04 | 1124 | 159 | 18 | MM1070 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 CRLF1 COL17A1 FN1 COL6A6 INHA PAPLN VWA1 ITIH5 FREM2 IGFALS FGFBP3 COL1A2 | 1.73e-04 | 1026 | 159 | 17 | M5889 |
| Coexpression | BENPORATH_PRC2_TARGETS | COL2A1 GJD2 CRLF1 MAPT PTF1A NKX3-2 SLITRK3 HMX2 ZFYVE28 EGR4 BARHL1 REPS2 PDZD2 | 1.75e-04 | 650 | 159 | 13 | M8448 |
| Coexpression | PRC2_EED_DN.V1_DN | 1.83e-04 | 193 | 159 | 7 | M2734 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 2.21e-04 | 199 | 159 | 7 | M7319 | |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP | 2.27e-04 | 200 | 159 | 7 | M6307 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN | 2.27e-04 | 200 | 159 | 7 | M7323 | |
| CoexpressionAtlas | EB amniotic fluid MSC_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | ZNF703 JPH4 CRLF1 COL17A1 MAPT APC2 INSM1 ARX BCL11A KIRREL2 GPRIN1 MIR1915HG PLEKHH3 ITIH5 ITPKB EGR2 RELL2 EGR4 BARHL1 MTCL1 SERTAD1 | 7.09e-08 | 727 | 154 | 21 | PCBC_ratio_EB amniotic fluid MSC_vs_EB blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | COL2A1 REPS1 COL17A1 INSM1 DVL2 TSEN54 DUSP15 BCL11A PAK6 ECPAS WNK1 TERF2 ZFYVE28 WDR91 LHX1 EGR2 DACT3 KNDC1 NAV1 RGL2 MTSS2 | 9.81e-06 | 989 | 154 | 21 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.62e-05 | 153 | 154 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | COL2A1 COL7A1 CLSTN3 COL16A1 CRLF1 COL17A1 DVL2 DUSP15 PAK6 ZFYVE28 LHX1 EGR2 DACT3 KNDC1 REPS2 COL1A2 | 2.31e-05 | 655 | 154 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#4 | 5.63e-05 | 92 | 154 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | COL2A1 SHANK1 ZNF703 COL7A1 JPH4 COL16A1 CRLF1 APC2 GLIS3 DUSP15 BCL11A LPIN3 LHX1 AATK EGR2 KNDC1 NAV1 REPS2 COL1A2 | 8.87e-05 | 978 | 154 | 19 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | COL2A1 BORCS6 ZNF703 CRLF1 COL17A1 BCL11A ARHGEF17 ADGRA2 ITPKB OSBPL5 DACT3 MBD2 TNS3 COL1A2 | 1.02e-04 | 589 | 154 | 14 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | COL2A1 ZNF703 COL7A1 CIART CALCOCO1 ARX ZBTB22 PEX6 ARHGEF17 PLEKHH3 ITPKB FREM2 BARHL1 NAV1 ARMCX6 AJUBA VPS37D TNS3 MTSS2 COL1A2 | 1.03e-04 | 1075 | 154 | 20 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_200 | 1.28e-04 | 14 | 154 | 3 | gudmap_developingGonad_P2_ovary_200_k2 | |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.57e-04 | 269 | 154 | 9 | ratio_EB-blastocyst_vs_EB-fibro_2500_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | COL4A1 FN1 INHA ARX DENND2B ITIH5 SMTN EGR2 NAV1 ARMCX6 C7 REPS2 TNS3 MTSS2 PDZD2 COL1A2 | 1.72e-04 | 777 | 154 | 16 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.91e-04 | 276 | 154 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | FN1 INHA ARX OBSL1 DENND2B ITIH5 SMTN EGR2 ZAR1 ARMCX6 C7 REPS2 TNS3 MTSS2 PDZD2 COL1A2 | 2.16e-04 | 793 | 154 | 16 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | COL2A1 SHANK1 ZNF703 COL7A1 CLSTN3 JPH4 COL16A1 CRLF1 ARID3A APC2 GLIS3 BCL11A PPP1R26 AATK DACT3 REPS2 PINK1 COL1A2 | 2.33e-04 | 967 | 154 | 18 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | cerebral cortex | SHANK1 CLSTN3 CCDC184 JPH4 GJD2 CRLF1 MAPT APC2 SLITRK3 BCAS1 PPFIA3 GPRIN1 KCNH4 DLGAP3 AATK SYNJ1 RELL2 EGR4 FGFBP3 KNDC1 FBXO41 DISP2 BSN | 2.57e-04 | 1428 | 154 | 23 | cerebral cortex |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | COL2A1 SHANK1 COL7A1 CLSTN3 JPH4 COL16A1 CRLF1 APC2 INSM1 GLIS3 DUSP15 BCL11A PAK6 FREM2 NAV1 MTCL1 REPS2 COL1A2 | 2.87e-04 | 984 | 154 | 18 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL7A1 COL16A1 APC2 BCAR1 ARHGEF17 PLEKHH3 ARMCX6 AJUBA PDZD2 | 1.67e-08 | 177 | 160 | 9 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL7A1 COL16A1 APC2 BCAR1 ARHGEF17 PLEKHH3 ARMCX6 AJUBA PDZD2 | 1.67e-08 | 177 | 160 | 9 | 8684d47a547e2a06496f15e8da0200ecddc431e0 |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.36e-08 | 192 | 160 | 9 | 430ef714bf2544d32f3fd96a55af010f79aa9be0 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.68e-08 | 194 | 160 | 9 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.78e-08 | 200 | 160 | 9 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-07 | 116 | 160 | 7 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.41e-07 | 175 | 160 | 8 | fa16c6ba08dc0cc22e8cf049db0577811d080df6 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-07 | 180 | 160 | 8 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-07 | 180 | 160 | 8 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.83e-07 | 186 | 160 | 8 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.83e-07 | 186 | 160 | 8 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.99e-07 | 187 | 160 | 8 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-07 | 189 | 160 | 8 | 9e1a51997ef9b6999d9b40cf0a55e561e3b4a84c | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.50e-07 | 190 | 160 | 8 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.50e-07 | 190 | 160 | 8 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-07 | 190 | 160 | 8 | 7f6dafd5418764d67f6d5ec2153233b791910e81 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-07 | 193 | 160 | 8 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.07e-07 | 193 | 160 | 8 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-07 | 193 | 160 | 8 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-07 | 193 | 160 | 8 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.48e-07 | 195 | 160 | 8 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.70e-07 | 196 | 160 | 8 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | wk_08-11-Epithelial-PNS-TM4SF4+_PENK+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.70e-07 | 196 | 160 | 8 | afa3a2f5f3a51d1830c6f95f97a4b3e13ed42512 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.15e-07 | 198 | 160 | 8 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.39e-07 | 199 | 160 | 8 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.63e-07 | 200 | 160 | 8 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 2.20e-06 | 164 | 160 | 7 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.48e-06 | 167 | 160 | 7 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.48e-06 | 167 | 160 | 7 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-06 | 171 | 160 | 7 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 175 | 160 | 7 | d2ff8fedca9039cbd45cfd9dec88f4edbe7fe4fc | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-06 | 175 | 160 | 7 | a7310950e8d51b3004ea3aee8ce9948fe8655112 | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.92e-06 | 179 | 160 | 7 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 3.92e-06 | 179 | 160 | 7 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.07e-06 | 180 | 160 | 7 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.07e-06 | 180 | 160 | 7 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 4.53e-06 | 183 | 160 | 7 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.70e-06 | 184 | 160 | 7 | 571136c832cb8c08457744152231537aa8e8abd7 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-06 | 184 | 160 | 7 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.87e-06 | 185 | 160 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.23e-06 | 187 | 160 | 7 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.23e-06 | 187 | 160 | 7 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.60e-06 | 189 | 160 | 7 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.60e-06 | 189 | 160 | 7 | cceca3d14dd559bbb2cb4b81ea12c2b62d18ee49 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.80e-06 | 190 | 160 | 7 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.80e-06 | 190 | 160 | 7 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.80e-06 | 190 | 160 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.80e-06 | 190 | 160 | 7 | 84fbd5664ec886120963d4f50dfa1fd1851d36c1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.00e-06 | 191 | 160 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.00e-06 | 191 | 160 | 7 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.00e-06 | 191 | 160 | 7 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.00e-06 | 191 | 160 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.00e-06 | 191 | 160 | 7 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.21e-06 | 192 | 160 | 7 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.21e-06 | 192 | 160 | 7 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.21e-06 | 192 | 160 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 193 | 160 | 7 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.43e-06 | 193 | 160 | 7 | dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.43e-06 | 193 | 160 | 7 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.43e-06 | 193 | 160 | 7 | 2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 6.65e-06 | 194 | 160 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.65e-06 | 194 | 160 | 7 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.65e-06 | 194 | 160 | 7 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.65e-06 | 194 | 160 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | facs-Thymus-Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 194 | 160 | 7 | 255d6eead8da740a942a5e7d554dbd895d736d1a | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT2-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.65e-06 | 194 | 160 | 7 | 5bfc26668fa8f109f2ebc0d5fd98ab5bd219e62c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.87e-06 | 195 | 160 | 7 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.11e-06 | 196 | 160 | 7 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-06 | 196 | 160 | 7 | 9d18381d7aaa063094a5df769a04c73350471525 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.11e-06 | 196 | 160 | 7 | e24a7aaf41793abba66c1189d933ca05b14c1af9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.11e-06 | 196 | 160 | 7 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-06 | 196 | 160 | 7 | a52cb512c6173be92aa9c4d96e2abbc32f45478d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-06 | 196 | 160 | 7 | afddacc0fb8b9c73dad5333137deb471a6ebdc06 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.11e-06 | 196 | 160 | 7 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-06 | 196 | 160 | 7 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.11e-06 | 196 | 160 | 7 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.35e-06 | 197 | 160 | 7 | 4edf043e8f586fd375f56485841fe992a18bf853 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.35e-06 | 197 | 160 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-06 | 197 | 160 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-06 | 197 | 160 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 7.59e-06 | 198 | 160 | 7 | b73b9feb82997b654718aa27f33ca7b454214802 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-06 | 198 | 160 | 7 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.59e-06 | 198 | 160 | 7 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.59e-06 | 198 | 160 | 7 | 50504a3871f76d6a5b439a56450d7770f4501eb0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.59e-06 | 198 | 160 | 7 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 7.85e-06 | 199 | 160 | 7 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 7.85e-06 | 199 | 160 | 7 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.85e-06 | 199 | 160 | 7 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.85e-06 | 199 | 160 | 7 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.85e-06 | 199 | 160 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.11e-06 | 200 | 160 | 7 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.11e-06 | 200 | 160 | 7 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.11e-06 | 200 | 160 | 7 | 410b1a31de21c57d87ca2104f61cf4a7d4dd2f30 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.11e-06 | 200 | 160 | 7 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| Drug | GK-101 | 4.78e-09 | 36 | 158 | 7 | CID000161853 | |
| Drug | Madecassol | 2.89e-08 | 46 | 158 | 7 | CID000108062 | |
| Drug | malotilate | 3.31e-08 | 71 | 158 | 8 | CID000004006 | |
| Drug | d-indobufen | 5.27e-08 | 50 | 158 | 7 | CID000044562 | |
| Drug | strontium ranelate | 6.31e-08 | 77 | 158 | 8 | CID006918182 | |
| Drug | ridogrel | 6.98e-08 | 52 | 158 | 7 | CID005362391 | |
| Drug | AC1L1C2F | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 KCNH4 COL1A2 | 7.58e-08 | 110 | 158 | 9 | CID000001711 |
| Drug | NSC49633 | 8.00e-08 | 53 | 158 | 7 | CID000023340 | |
| Drug | halofuginone lactate | 1.38e-07 | 85 | 158 | 8 | CID000062891 | |
| Drug | 4-hydroxyproline | 2.35e-07 | 91 | 158 | 8 | CID000000825 | |
| Drug | AC1LAKND | 2.42e-07 | 62 | 158 | 7 | CID000470146 | |
| Drug | khellin | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 KCNH4 ACTL7B COL1A2 | 3.37e-07 | 171 | 158 | 10 | CID000003828 |
| Drug | ticlopidine | 6.13e-07 | 103 | 158 | 8 | CID000005472 | |
| Drug | BAPN | 6.22e-07 | 71 | 158 | 7 | CID000001647 | |
| Drug | candesartan cilexetil | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 ACTL7B COL1A2 | 8.05e-07 | 145 | 158 | 9 | CID000002540 |
| Drug | AC1NMZ1B | 9.06e-07 | 75 | 158 | 7 | CID005034185 | |
| Drug | hydroxylysine | 9.45e-07 | 109 | 158 | 8 | CID000001029 | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | COL7A1 BCORL1 BCAS1 PPFIA3 TAOK2 WDR91 CASKIN2 RIN2 ELK1 INVS | 1.07e-06 | 194 | 158 | 10 | 3303_DN |
| Drug | PPACK | 1.24e-06 | 113 | 158 | 8 | CID003036757 | |
| Drug | L-lysyl-L-lysyl-L-lysine | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 BCAR1 COL1A2 | 2.03e-06 | 162 | 158 | 9 | CID000072363 |
| Drug | DMSe | 4.00e-06 | 132 | 158 | 8 | CID000020796 | |
| Drug | AC1Q6PCP | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 SLC12A2 OSBPL5 COL1A2 | 4.94e-06 | 230 | 158 | 10 | CID000005267 |
| Drug | pirfenidone | 5.57e-06 | 138 | 158 | 8 | CID000040632 | |
| Drug | DL-penicillamine | 5.88e-06 | 139 | 158 | 8 | CID000004727 | |
| Drug | foscarnet | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 ACTL7B BSN COL1A2 | 7.48e-06 | 190 | 158 | 9 | CID000003414 |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 8.49e-06 | 193 | 158 | 9 | 3262_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 8.85e-06 | 194 | 158 | 9 | 4961_UP | |
| Drug | Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | CDK16 COL7A1 PTDSS2 PPFIA3 ADGRA2 ZNF446 C2CD2L PTPRM CASKIN2 | 8.85e-06 | 194 | 158 | 9 | 4951_UP |
| Drug | Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 8.85e-06 | 194 | 158 | 9 | 5454_DN | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A | 9.22e-06 | 195 | 158 | 9 | 5117_DN | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.00e-05 | 197 | 158 | 9 | 7202_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; PC3; HT_HG-U133A | 1.00e-05 | 197 | 158 | 9 | 6683_UP | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.00e-05 | 197 | 158 | 9 | 2779_UP | |
| Drug | AC1L9732 | 1.50e-05 | 114 | 158 | 7 | CID000439300 | |
| Drug | colchine | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 MAPT ACTL7B BSN PDZD2 COL1A2 | 1.57e-05 | 383 | 158 | 12 | CID000002833 |
| Drug | Tranilast sodium | 1.59e-05 | 115 | 158 | 7 | CID000005527 | |
| Drug | Selara | 2.73e-05 | 125 | 158 | 7 | CID000150310 | |
| Drug | AC1L1KMJ | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 FN1 PLEKHG4 APC2 BCAR1 ACTL7B SLC12A2 COL1A2 | 2.93e-05 | 476 | 158 | 13 | CID000030956 |
| Drug | Cefuroxime-d3 | 2.96e-05 | 26 | 158 | 4 | CID000002658 | |
| Drug | AC1L1DD6 | 3.69e-05 | 179 | 158 | 8 | CID000002299 | |
| Drug | kalinin | 3.97e-05 | 55 | 158 | 5 | CID000032518 | |
| Drug | PCR 4099 | 5.38e-05 | 139 | 158 | 7 | CID000002806 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 5.42e-05 | 189 | 158 | 8 | CID000001413 | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A | 5.83e-05 | 191 | 158 | 8 | 3815_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 6.28e-05 | 193 | 158 | 8 | 7008_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.28e-05 | 193 | 158 | 8 | 5239_DN | |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; MCF7; HT_HG-U133A | 6.75e-05 | 195 | 158 | 8 | 2868_UP | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 6.75e-05 | 195 | 158 | 8 | 3409_DN | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 6.75e-05 | 195 | 158 | 8 | 3503_DN | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; PC3; HT_HG-U133A | 6.75e-05 | 195 | 158 | 8 | 6293_UP | |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 1323_UP | |
| Drug | Sulfaphenazole [526-08-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 1673_UP | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; HL60; HG-U133A | 6.99e-05 | 196 | 158 | 8 | 1370_DN | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 2784_UP | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 1691_DN | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 2751_DN | |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 6610_DN | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 5830_DN | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; PC3; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 6676_UP | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 158 | 8 | 6519_DN | |
| Drug | Urosiol [128-13-2]; Up 200; 10.2uM; HL60; HT_HG-U133A | 7.25e-05 | 197 | 158 | 8 | 3105_UP | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A | 7.25e-05 | 197 | 158 | 8 | 4474_DN | |
| Drug | Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 158 | 8 | 2279_UP | |
| Drug | Flufenamic acid [530-78-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 158 | 8 | 2267_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 158 | 8 | 3937_DN | |
| Drug | Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 158 | 8 | 7230_DN | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 158 | 8 | 3877_DN | |
| Drug | Y 27632 | 7.47e-05 | 101 | 158 | 6 | ctd:C108830 | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 3305_DN | |
| Drug | cox-2 inhibitor I; Down 200; 10uM; MCF7; HG-U133A | 7.51e-05 | 198 | 158 | 8 | 612_DN | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 3722_UP | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 7331_UP | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 3337_UP | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; PC3; HG-U133A | 7.51e-05 | 198 | 158 | 8 | 1895_UP | |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 2090_UP | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; PC3; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 3706_DN | |
| Drug | Gelsemine [509-15-9]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 2817_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; PC3; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 3728_UP | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 7.78e-05 | 199 | 158 | 8 | 1509_DN | |
| Drug | Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 7.78e-05 | 199 | 158 | 8 | 7237_DN | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; PC3; HT_HG-U133A | 7.78e-05 | 199 | 158 | 8 | 5090_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Up 200; 14.8uM; PC3; HT_HG-U133A | 7.78e-05 | 199 | 158 | 8 | 6629_UP | |
| Drug | rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.78e-05 | 199 | 158 | 8 | 5975_DN | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 8.05e-05 | 200 | 158 | 8 | 4740_UP | |
| Drug | fullerene C60 | COL2A1 ZNF703 COL7A1 CRLF1 KIF26A APC2 PEX6 DUSP15 LHX3 BCAR1 HMX2 GPRIN1 SMTN C2CD2L ACTL7B FREM2 CASKIN2 RELL2 OSBPL5 STRN4 ARMCX6 BSN RGL2 PDZD2 | 1.05e-04 | 1498 | 158 | 24 | ctd:C069837 |
| Drug | p-methoxybenzeneselenol | 1.43e-04 | 3 | 158 | 2 | CID006336649 | |
| Drug | balofloxacin | 2.03e-04 | 42 | 158 | 4 | CID000065958 | |
| Drug | Collagenase | 2.85e-04 | 4 | 158 | 2 | DB00048 | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; PC3; HT_HG-U133A | 3.07e-04 | 184 | 158 | 7 | 4439_UP | |
| Drug | Tamoxifen citrate [54965-24-1]; Up 200; 7uM; MCF7; HT_HG-U133A | 3.39e-04 | 187 | 158 | 7 | 6768_UP | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 3.50e-04 | 188 | 158 | 7 | 1023_UP | |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL4A1 COL4A3 COL7A1 COL16A1 COL17A1 LHX1 KDM1A COL1A2 | 3.59e-04 | 314 | 158 | 9 | CID000447989 |
| Drug | prostacyclin sodium salt | 3.69e-04 | 250 | 158 | 8 | CID000000159 | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; PC3; HT_HG-U133A | 4.09e-04 | 193 | 158 | 7 | 3989_UP | |
| Drug | Pyrithyldione [77-04-3]; Down 200; 24uM; PC3; HT_HG-U133A | 4.09e-04 | 193 | 158 | 7 | 7153_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.22e-04 | 194 | 158 | 7 | 7001_UP | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 4.22e-04 | 194 | 158 | 7 | 4678_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.22e-04 | 194 | 158 | 7 | 1001_UP | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 4.22e-04 | 194 | 158 | 7 | 5998_DN | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 4.22e-04 | 194 | 158 | 7 | 3431_DN | |
| Disease | SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE | 2.71e-05 | 2 | 154 | 2 | 184255 | |
| Disease | Spondylometaphyseal dysplasia - Sutcliffe type | 2.71e-05 | 2 | 154 | 2 | cv:C0432221 | |
| Disease | Spondylometaphyseal dysplasia, 'corner fracture' type | 2.71e-05 | 2 | 154 | 2 | C0432221 | |
| Disease | complex cortical dysplasia with other brain malformations (is_implicated_in) | 1.61e-04 | 4 | 154 | 2 | DOID:0090131 (is_implicated_in) | |
| Disease | Hematuria, Benign Familial | 1.61e-04 | 4 | 154 | 2 | C0241908 | |
| Disease | Sensorineural Hearing Loss (disorder) | 2.29e-04 | 23 | 154 | 3 | C0018784 | |
| Disease | Alport Syndrome, X-Linked | 2.68e-04 | 5 | 154 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 2.68e-04 | 5 | 154 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 2.68e-04 | 5 | 154 | 2 | C1567744 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 2.77e-04 | 60 | 154 | 4 | C4722327 | |
| Disease | hypertensive nephropathy | 4.00e-04 | 6 | 154 | 2 | C0848548 | |
| Disease | early-onset Parkinson's disease (implicated_via_orthology) | 4.00e-04 | 6 | 154 | 2 | DOID:0060894 (implicated_via_orthology) | |
| Disease | Hyalinosis, Segmental Glomerular | 4.15e-04 | 28 | 154 | 3 | C0086432 | |
| Disease | Prostate cancer, familial | 4.74e-04 | 69 | 154 | 4 | C2931456 | |
| Disease | Parkinsonism, Juvenile | 5.10e-04 | 30 | 154 | 3 | C0752105 | |
| Disease | Spondylometaphyseal dysplasia | 5.59e-04 | 7 | 154 | 2 | cv:C4759767 | |
| Disease | Type II Collagenopathies | 5.59e-04 | 7 | 154 | 2 | cv:CN043672 | |
| Disease | Global developmental delay | 6.82e-04 | 133 | 154 | 5 | C0557874 | |
| Disease | Disproportionate short stature | 7.18e-04 | 77 | 154 | 4 | C0878659 | |
| Disease | zinc-alpha-2-glycoprotein measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0802228 | |
| Disease | disease recurrence, malaria | 7.42e-04 | 8 | 154 | 2 | EFO_0001068, EFO_0004952 | |
| Disease | Focal glomerulosclerosis | 8.77e-04 | 36 | 154 | 3 | C0017668 | |
| Disease | Developmental delay (disorder) | 9.51e-04 | 37 | 154 | 3 | C0424605 | |
| Disease | Congenital small ears | 1.28e-03 | 41 | 154 | 3 | C0152423 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.43e-03 | 157 | 154 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | response to methotrexate, serum alanine aminotransferase measurement | 1.48e-03 | 43 | 154 | 3 | EFO_0004735, GO_0031427 | |
| Disease | collagen disease (implicated_via_orthology) | 1.73e-03 | 12 | 154 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.73e-03 | 12 | 154 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | neurotic disorder | 1.97e-03 | 101 | 154 | 4 | EFO_0004257 | |
| Disease | FEV/FEC ratio | COL4A1 GLIS3 TSEN54 BCL11A ARHGEF17 DENND2B SMTN PRR12 FREM2 PTPRM TSPAN10 NAV1 MTCL1 AJUBA MBD2 | 1.98e-03 | 1228 | 154 | 15 | EFO_0004713 |
| Disease | cigarettes per day measurement | 2.20e-03 | 438 | 154 | 8 | EFO_0006525 | |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 2.36e-03 | 14 | 154 | 2 | EFO_0004307, EFO_0008464 | |
| Disease | Myopia | 2.72e-03 | 15 | 154 | 2 | C0027092 | |
| Disease | breast carcinoma | SHANK1 MAPT PTDSS2 BCAS1 GIPR DLGAP3 SLC12A2 EGR2 RIN2 MTCL1 ZC3H7B PCNT COL1A2 | 2.73e-03 | 1019 | 154 | 13 | EFO_0000305 |
| Disease | sleep duration | 3.01e-03 | 362 | 154 | 7 | EFO_0005271 | |
| Disease | T-Cell Lymphoma | 3.10e-03 | 16 | 154 | 2 | C0079772 | |
| Disease | Abnormal behavior | 3.10e-03 | 16 | 154 | 2 | C0233514 | |
| Disease | macula measurement | 3.20e-03 | 189 | 154 | 5 | EFO_0008375 | |
| Disease | Dementia | 3.50e-03 | 17 | 154 | 2 | C0497327 | |
| Disease | cortical surface area measurement | COL2A1 REPS1 MAPT GLIS3 MIR1915HG ADGRA2 ITIH5 NHSL1 PCGF6 SF3B1 NAV1 MTCL1 AJUBA KDM1A PDZD2 | 4.64e-03 | 1345 | 154 | 15 | EFO_0010736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGPPGASGDGSLLSL | 1111 | Q9UMD9 | |
| SLLGGPGPERTPGSG | 326 | P19419 | |
| PGPERTPGSGSGSGL | 331 | P19419 | |
| TTAPRGPCIGPGAGE | 51 | Q9H0I2 | |
| DPGEAGTRPGPDASL | 16 | Q9Y614 | |
| DGSTPPASRGLPGTG | 216 | Q7RTU5 | |
| RVSGAGGPPGASSDP | 876 | Q9BQT9 | |
| LDRDPPESIGGPGGT | 116 | Q9UKL4 | |
| PGIPGLDRSGFPGET | 841 | Q01955 | |
| QPLAPGRTGGLGPSD | 726 | P56945 | |
| GSARVGTPGPPEDGD | 996 | Q96PE1 | |
| GATGGPGDEPLEPAR | 51 | Q96IF1 | |
| GDPGTPGTTGRPGLS | 691 | Q07092 | |
| PGTTGRPGLSGEPGV | 696 | Q07092 | |
| GSEGIRGPSGLPGSP | 1186 | Q07092 | |
| GGPAAAGEGRVLPSP | 106 | P86434 | |
| TGTPRPGGASGPGLD | 61 | Q9BZE3 | |
| PGGLDDRSPPGSSET | 1746 | Q5H9F3 | |
| PGPSGPGGRRDSSIQ | 61 | Q7RTS1 | |
| AGREPGPGSSTKGPV | 71 | Q96L96 | |
| GPESPEGSPRGSEAA | 181 | Q3C1V8 | |
| GPRSLEGADPGTPGE | 21 | P35858 | |
| LPSGSGPGEVPTSRG | 431 | P48546 | |
| GRGVAPGPGFPSLEE | 346 | Q8N531 | |
| GEAGPPPEREGSGST | 346 | P78524 | |
| EPPATPAGLGSGGDR | 111 | Q09019 | |
| RGGPGDGSPVVLPNS | 1366 | A7MBM2 | |
| EASGTSDGGPPPSRG | 636 | O14641 | |
| TEPGAPGGTEDRPSG | 76 | Q7L4S7 | |
| GLTGPAGEPGREGSP | 1026 | P02458 | |
| RGFPGTSLPGPSGRD | 396 | P02462 | |
| TGPGASGGSEGPRLP | 281 | P11161 | |
| AQPVGPPSRVEGGSG | 341 | Q96DU7 | |
| SRARGSPGDTKGGPP | 1536 | Q9Y4B5 | |
| EGSPGGEASPGRPRL | 376 | Q9HCC9 | |
| PLDGRDSPSAGGPVG | 501 | Q96PE2 | |
| GEGRGARPQPTPSGS | 21 | Q8N9V6 | |
| PGSGEGAPVFLTGPR | 121 | O75147 | |
| RGVPTPSGDRGPGAA | 21 | Q5T4H9 | |
| VAEPVPGPTGGSSGR | 36 | Q8TAT2 | |
| PGPTGGSSGRFLSPE | 41 | Q8TAT2 | |
| LEGRAGATSPPRGGP | 266 | Q9BQK8 | |
| SATGRPGGEGSPSPK | 236 | Q9NQU5 | |
| VPGTLGEVPAAGSPG | 46 | P43359 | |
| SPGVGSSAGPPGDLE | 406 | O75420 | |
| RGSGRGEDDSGPPPS | 211 | Q86UX2 | |
| PSSRPGSGGDRGAAP | 101 | Q9NVR5 | |
| GSLEDGGPPRGSEGT | 736 | O75145 | |
| GGPPRGSEGTPDSLH | 741 | O75145 | |
| EGQSRPLTGPAGSGP | 451 | Q5SZK8 | |
| EVGSTGPPGSEASGP | 251 | Q96JJ6 | |
| GPGRVEPGSLESSPG | 476 | Q92615 | |
| SSGRPGKEPGEPGVL | 3261 | Q9UPA5 | |
| TPPGELDGGISGRSG | 701 | Q9H165 | |
| GRNGPLPIPSEGSGF | 821 | Q5VYK3 | |
| GGPVSRSPGAPSAGE | 1161 | Q5SYE7 | |
| PGTSAPGEGQERAPG | 196 | Q9BXM7 | |
| SGGTLGPSGEEAPRP | 411 | Q765P7 | |
| GVPRNSIPGGPSGED | 2196 | O15018 | |
| LSDRLGPGSGPLGEP | 251 | Q13608 | |
| DLGSPGPGSRRGGSP | 81 | A6NMT0 | |
| AGSPSPGSERPRDGG | 126 | A2RU54 | |
| SGSGRAGTPGEPRAP | 46 | Q9NP85 | |
| TEAESGAEPGGGPRP | 726 | Q9UQ05 | |
| SSGPSGTPLGGLEHP | 316 | P48742 | |
| DTSLGLVPSGAPGGP | 341 | Q9UBR4 | |
| GSSGFLGPDRPDSPG | 1156 | Q9ULI4 | |
| EGAEGLPGLLTPPSG | 381 | Q05215 | |
| LSPGSGGPEAQTAGP | 2351 | O95613 | |
| PEGTPPSRGSSGEGL | 936 | Q8WXE0 | |
| LAPPSSGGLGEPDDG | 81 | Q7RTS3 | |
| SGSAGPGPRGPRATE | 131 | Q9UBB5 | |
| GLAAPEGRPAPGGTA | 26 | P78367 | |
| VTKDPGPGGGRDSSP | 1606 | O95996 | |
| GPGGGRDSSPSPRAA | 1611 | O95996 | |
| GTAGPSGPSGLPGER | 631 | P08123 | |
| PAGLSGPAEVGPGAV | 41 | O60341 | |
| GGGPGRTSSEPPAGL | 26 | Q96GS4 | |
| PTDSPDAGGAGRPLD | 236 | Q96B18 | |
| RGPGPALAGEPAGSL | 46 | O14523 | |
| GSDPGEAPTRAAPGE | 41 | Q00536 | |
| RPGGEPSPEGTTGQS | 2426 | P02751 | |
| ERPDGSSTPGNPDGI | 261 | Q9H1R2 | |
| AAAEGTVGRSPGPGP | 536 | Q8NEA6 | |
| PPPSGGGRSCVGETT | 526 | P10643 | |
| GPLSLSEGPSVGPEG | 61 | O95886 | |
| LGGGSRDLSPEPAPD | 176 | Q8TBE0 | |
| RPEEGAPEDSGPGGL | 426 | Q8TF61 | |
| REPASGEPPSGSGRG | 396 | Q96SL8 | |
| PEERLGVAGGPGSAP | 201 | Q96QS3 | |
| SLTGEEPLPGGSPGG | 1006 | O75064 | |
| LGPPAVTREGGDPGV | 41 | P05111 | |
| TFPAPESRGGLGPGL | 451 | Q6UWL6 | |
| RSTDRGPGVPGSPGQ | 381 | Q76NI1 | |
| ETGPPGRGLTGPTGA | 2211 | Q02388 | |
| SSGPGDPRSLGTAGP | 491 | Q7Z2K8 | |
| TLLPPETGGAGGEAP | 171 | O75363 | |
| PEGTPAGRARGGSPA | 1401 | Q9NZM4 | |
| GPLLGPEAAPSGEGA | 26 | Q9BRJ6 | |
| ASTPRSERPGPGGGA | 336 | O75462 | |
| PLPSSGPDFGGLGEE | 11 | Q9Y512 | |
| ERGDPGSSPAGPREA | 556 | Q9P1Z2 | |
| PSPGIGDSGLLGRDP | 121 | Q52MB2 | |
| PGAPGVDSSIEGPTG | 1511 | A6NMZ7 | |
| LTPPAGAGPSGETGA | 1051 | Q05469 | |
| TRPGEGGTGSPGPAL | 356 | P28827 | |
| GEEGPAPLSETGAPG | 41 | Q9BYE7 | |
| GMPEEPATTARGGPG | 116 | O96013 | |
| QGPEPRDSRGSPGGS | 651 | Q9Y283 | |
| EAPGGGSDRDTPSPG | 341 | Q01101 | |
| GRDGEPGTSPDASPS | 256 | Q9H0X9 | |
| GRTGPKEGTPGSPSE | 506 | Q9NZT2 | |
| GSSPLGPAGLGAEEP | 46 | O43482 | |
| GGRGGPRPVSSSIDP | 686 | Q8NEY1 | |
| GTPPSEGGGGSFPRI | 751 | O15211 | |
| AGGRGPSPGLPTQEA | 266 | Q8NC24 | |
| TPSPAGGGRGPLEVT | 46 | Q7Z736 | |
| SGGNSERPLAGPGPF | 186 | Q96D71 | |
| LGSLGPSPGPAREGV | 261 | Q7Z6J9 | |
| EFGGIGAPPSPGVAR | 1141 | O43426 | |
| SRASLDPGGGPQGVP | 141 | Q6ZUX3 | |
| GVDSGPRVPGASPGF | 11 | Q2M2I3 | |
| GGDRAPGPELGLPST | 1016 | Q6ZMQ8 | |
| DTPGVGLVGDPGPSR | 121 | Q58EX7 | |
| GSETSPAPERGGPRD | 351 | P27987 | |
| GRASLEEPPDGPSAG | 21 | Q9BVG9 | |
| EAGSAERGGPGTQPP | 771 | O94933 | |
| EEGAPIGTPRDPGDG | 906 | Q9UL54 | |
| EGPTALGTGGPARPE | 861 | Q5T8A7 | |
| LGREPGGPPGSFLTS | 826 | O95785 | |
| GSELLAGPGGPPAER | 621 | Q9ULL5 | |
| ADEGPPGRSIGGAAP | 136 | Q9UHV2 | |
| GFGTAPVGSGLPPEE | 1021 | Q68CZ2 | |
| PEAGSPGSGVPDFGR | 56 | Q9H0A9 | |
| TRDSQGEPGGPGLPA | 376 | Q7Z5H3 | |
| EEDSGLSPGPSPGSG | 151 | Q499Z3 | |
| SDSSPDGPGRGPRGT | 26 | Q9Y566 | |
| EEGLGPPGPASLGTT | 156 | Q99856 | |
| PDTVGQRGGSRPSPG | 46 | Q8N365 | |
| TRPGEAGPGASGPES | 301 | Q6PCB0 | |
| PELELGTAGSPGGAP | 386 | Q8WYP3 | |
| PSPEPAAVSRGGGGE | 251 | Q9H7S9 | |
| AQGGGPPLSPEELGS | 291 | O15156 | |
| PEGSSSGGPGTKPLR | 236 | Q8NFH8 | |
| PGLRGTTEPDATGGG | 441 | Q2M3V2 | |
| SRAPGLGGDAGSPAP | 886 | O95428 | |
| PGRAKGSETPGATPG | 236 | O75533 | |
| TPAGAATPGRGDTPG | 261 | O75533 | |
| PAAAGDGLGRPLGPT | 61 | P55011 | |
| GGDGDRASPGSPGPL | 246 | P0DPE3 | |
| SLGPGISGPRGQAPD | 251 | Q4KMP7 | |
| PGEGPEARGPSLGED | 331 | P10636 | |
| DRGSPGDTGERPAGP | 26 | A8MTW9 | |
| PEPGSPGRFGILSTG | 11 | Q86XT2 | |
| GSPHPSGTVESPGEG | 136 | Q9NWS9 | |
| GSLGSDLGGPLPTDP | 106 | Q9H1Z9 | |
| SGSGAREEAPGEAPP | 66 | O60346 | |
| RAPPGPAGLSGGESL | 221 | Q9NRL3 | |
| EEPPPARSGSGGGSA | 176 | Q9H4A3 | |
| PGRPEEPSESGLGVG | 16 | Q9H4Z2 | |
| GLASPGGQPSPEGAT | 826 | Q9H4Z2 | |
| SSAGPEGGGVRPEQP | 381 | A4D1P6 | |
| DAPLAGSEPGPGLGV | 76 | A0A286YF58 | |
| GAPLPVAVGTAEPGG | 441 | P53814 | |
| GTAGPASGPGVVRDP | 6 | Q15554 | |
| GPVAGLDDSGGPTPS | 391 | O15209 | |
| GGPEPRSSGRKASGP | 31 | Q8NBV4 | |
| ARDPESPAGPGAEGT | 131 | Q86SH2 | |
| PGKPGEGTPISSREG | 811 | Q9UGR2 | |
| PEGLTPAHLGEPGGS | 121 | O14686 | |
| RPPTTGGSEGAGAAP | 476 | Q9P206 | |
| RSVGAPGGAPTPALG | 831 | Q9P206 |